FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian Environment

FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian Environment

Accelerated approval (AA) by the FDA enables earlier access to promising new therapies. Health Canada has a similar process. Canada implemented a national health technology assessment (HTA) for reimbursement decisions in 2011. This study evaluated regulatory and funding timelines and decisions for F...

Full description

Bibliographic Details
Main Authors: Cheryl Ho, Howard J. Lim, Dean A. Regier
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Current Oncology
Subjects:
accelerated approval
FDA
Health Canada
health technology assessment
CADTH
Online Access:https://www.mdpi.com/1718-7729/29/2/36

Internet

https://www.mdpi.com/1718-7729/29/2/36

Similar Items